1/🧵Human ClpP protease is targeted in cancer therapy with the activator ONC201 @chimerix Yet all structures of ClpP have captured it in its inactive state, even when bound to activators! ClpP is paradoxically activated by inhibitors at low concentrations before inhibition starts
Please share:
Hot off the press in NAR @OxfordJournals
We solve the structure of the elusive “pixel” domain within human PML protein that looks like a nuclease but is not.
Very proud of this collaboration with the Weller and Hao labs at UConnHealth.
https://t.co/RNKsjtgBn9
📢CONGRATULATIONS TO DR. MADISON TURNER on successfully defending her thesis on "Allosteric regulation of the Mycobacterium tuberculosis proteasome"👏👨🎓🥂🎉
🗓️August 20th
🔬Vahidi Lab
📢CONGRATULATIONS TO DR. BRADLEY DAVIS on successfully defending his thesis on the "Substrate engagement mechanism of the bacterial proteasome activator Bpa"! 🎉👏🥳
🗓️August 13th
🔬Vahidi Lab
📣CONGRATULATIONS TO DR. MONICA GONCALVES on successfully defending her thesis on "Mechanisms of allosteric regulation in human mitochondrial ClpP protease"!👏👏🍾🎉
🗓️August 25th
🔬Vahidi Lab
SickKids' Sr. Scientist Dr. Lewis Kay has received a prestigious 2026 Royal Medal from The Royal Society.
In a new Q&A, Dr. Kay opens up about his journey, priorities and legacy ⬇️
https://t.co/SsZO1fORNb
📣CONGRATULATIONS TO JACQUELYN OGATA-BEAN on successfully defending her thesis on "De novo design and characteri-589! of human mitochondrial ClpP activators"!👏👏🍾🎉
🗓️August 18th
🔬Vahidi Lab
After a while not posting, happy to share our latest paper on how the different J-domains interact with the various HSP70s! Proud of Roni and of the outcome🏆 @PNASNews
https://t.co/zX63iqVlnF
#UofT Professor Raquel Urtasun and John Rubinstein, senior scientist at @SickKidsNews and professor at @uoftmedicine, have been elected 2026 Fellows of the @royalsociety, the U.K.'s national academy of sciences https://t.co/TvER10KPFu
The ubiquitous biology of intracellular protein degradation: a tribute to Alfred L. (“Fred”) Goldberg. The review articles in this series highlight key areas shaped and inspired by his enduring contributions.
https://t.co/MSmwZbe0jt
Researchers at the University of Guelph & University of Toronto, led by Siavash Vahidi @VahidiLab and Lewis E. Kay @LEK_Lab together with Waters Corp, used NMR to identify a potential drug target in the tuberculosis stress-response system https://t.co/Ro438o5kqi #NMRchat#NMR 🧲
Can enzymes retain catalytic activity in the gas phase? Using tandem MS, molecular dynamics simulations, and enzyme variants courtesy of the @VahidiLab, Kirsty (@kirstynyk) uncovers new insight towards this question.
Now published in JACS (@J_A_C_S)!
https://t.co/7GQLvBTEdy
CIHR funding rate: 13.6%.
Early 2000s: 30%+.
Canada’s new $1.7B Impact+ program recruits talent — but without increased Tri-Council base funding, we risk further strain on an already stretched system.
We’re calling for $1B over 5 years.
Support here: https://t.co/iknRwlOqvM
Join 2026 BPS Lecturer Lewis Kay on Tuesday, February 24, 2:00 PM - 3:00 PM at #bps2026 for an informal discussion. Dr. Kay will share insights from his scientific career—from pioneering discoveries to lessons learned along the way—and reflect on how the field continues to evolve
MCB @ U of Guelph is hiring (again)! 🎉
Tenure-track Assistant Professor in Biochemistry
Part of our strategic cluster hire.
Apply now 👉 https://t.co/rj68ZBWlbs
#Biochemistry#FacultyJobs#AcademicTwitter#MolBio
Out in @pnas today
Showcasing the power of NMR!
NMR and enzyme kinetics show USP7 enzyme transiently sampling a low-populated active state, and its disease-causing variant enhancing these dynamics
https://t.co/g1SmP4nBox
Stellar work by students Gabi Valles and Emilie Korchak